PTC Therapeutics: Navigating Revenue Challenges and Uncertain Outlook Amidst DMD Franchise Erosion
Leerink Partners analyst Joseph Schwartz has maintained their neutral stance on PTCT stock, giving a Hold rating yesterday.Stay Ahead of the ...
PTC Therapeutics price target lowered at Cantor Fitzgerald, a top pick in 2025
Cantor Fitzgerald lowered the firm’s price target on PTC Therapeutics (PTCT) to $76 from $80 and keeps an Overweight rating on the shares. The ...
Smart Demand Response Market to Worth USD 123.66 Billion by 2032, Revolutionizing Global Energy Optimization | Research by SNS Insider
Rising energy costs and the integration of advanced technologies like AI and IoT are driving the adoption of smart demand response systems globally.Austin, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Market ...
Manufacturing Robot Installed Base to Hit 16.3 Million by 2030 Amid Baby Boomer Exodus
In January 2024, the U.S. Bureau of Labor Statistics reported that U.S. manufacturers had over six hundred thousand vacancies. Two factors affecting the number of vacancies include not enough young ...